We hypothesized that clinical resistance to 5-HT ( 3 ) antagonists is associated with the single-nucleotide polymorphism ( 3435C>T ) in the gene that codes for the drug efflux transporter adenosine triphosphate -binding cassette subfamily B member 1 ( ABCB1 ) .